117
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42

ORCID Icon, , , &
Pages 3477-3485 | Published online: 23 Dec 2021

References

  • Laurell CB, Eriksson S. The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest. 1963;15:132–140.
  • Strnad P, McElvaney NG, Lomas DA, Longo DL. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382(15):1443–1455. doi:10.1056/NEJMra1910234
  • Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294:1316–1321.
  • Bernspang E, Wollmer P, Sveger T, Piitulainen E. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals. Respir Med. 2009;103(6):861–865. doi:10.1016/j.rmed.2008.12.021
  • Piitulainen E, Montero LC, Nystedt-Düzakin M, et al. Lung function and CT densitometry in subjects with alpha-1-antitrypsin deficiency and healthy controls at 35 years of age. COPD. 2015;12(2):162–167. doi:10.3109/15412555.2014.922068
  • Mostafavi B, Diaz S, Piitulainen E, et al. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. 2018;13:3689–3698. doi:10.2147/COPD.S167497
  • Ferrer M, Villasante C, Alonso J, et al. Interpretation of quality of life scores from the St George’s respiratory questionnaire. Eur Respir J. 2002;19(3):405–413. doi:10.1183/09031936.02.00213202
  • Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026–1041. doi:10.1183/09031936.03.00089403
  • Quanjer P, Tammeling GJ, Cotes J, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40. doi:10.1183/09041950.005s1693
  • Yman L. Standardization of in vitro methods. Allergy. 2001;56(Suppl s67):70–74. doi:10.1111/j.1398-9995.2001.00921.x
  • Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–615. doi:10.1164/rccm.9120-11ST
  • Taylor DR, Pijnenburg MW, Smith AD, et al. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006;61(9):817–827. doi:10.1136/thx.2005.056093
  • Kim J-H, Park S, Hwang YI, et al. Immunoglobulin G subclass deficiencies in adult patients with chronic airway diseases. J Korean Med Sci. 2016;31(10):1560–1565. doi:10.3346/jkms.2016.31.10.1560
  • Schauer U, Stemberg F, Rieger CHL, et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem. 2003;49(11):1924–1929. doi:10.1373/clinchem.2003.022350
  • Mostafavi B, Piitulainen E, Tanash HA. Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43–45 years. Int J Chron Obstruct Pulmon Dis. 2019;14:525–530. doi:10.2147/COPD.S183205
  • Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax. 1997;52(3):244–248. doi:10.1136/thx.52.3.244
  • Eden E, Mitchell D, Mehlman B, et al. Atopy, asthma, and emphysema in patients with severe α−1-antitrypsin deficiency. Am J Respir Crit Care Med. 1997;156(1):68–74. doi:10.1164/ajrccm.156.1.9508014
  • Reid PA, Reid PT. Occupational lung disease. J R Coll Physicians Edinb. 2013;43(1):44–48. doi:10.4997/JRCPE.2013.111
  • Piitulainen E, Tornling G, Eriksson S. Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ). Thorax. 1998;53(11):939–943. doi:10.1136/thx.53.11.939
  • Santos S, Marín A, Serra-Batlles J, et al. Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation. Int J Chron Obstruct Pulmon Dis. 2016;11:515–525. doi:10.2147/COPD.S98333
  • Morell A. Clinical relevance of IgG subclass deficiencies. Ann Biol Clin. 1994;52:49–52.
  • Piitulainen E, Mostafavi B, Tanash HA. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37–40 years. Int J Chron Obstruct Pulmon Dis. 2017;12:495–500. doi:10.2147/COPD.S120241
  • Wall M, Moe E, Eisenberg J, et al. Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr. 1990;116(2):248–251. doi:10.1016/S0022-3476(05)82882-3
  • Kimpen J, Bosmans E, Raus J. Neonatal screening for alpha-1-antitrypsin deficiency. Eur J Pediatr. 1988;148(1):86–88. doi:10.1007/BF00441823